OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report)’s share price shot up 3% during trading on Thursday . The company traded as high as $1.04 and last traded at $1.03. 11,243 shares traded hands during trading, a decline of 91% from the average session volume of 131,748 shares. The stock had previously closed at $1.00.
Analysts Set New Price Targets
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price target on shares of OKYO Pharma in a research note on Tuesday, August 27th.
View Our Latest Report on OKYO Pharma
OKYO Pharma Trading Up 3.9 %
About OKYO Pharma
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.
Recommended Stories
- Five stocks we like better than OKYO Pharma
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- How to Calculate Inflation Rate
- MarketBeat Week in Review – 9/30 – 10/4
- What is the Euro STOXX 50 Index?
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
